BIRC5 and prostate carcinoma: Survivin was reported to be a possible biomarker for the diagnosis and prognosis of prostate cancer, as survivin levels were elevated in exosomes isolated from plasma/serum samples of prostate cancer patients as compared to those isolated from healthy males [37].